Table 2. Influence of Scheduled Dialysis on Health Care Utilization and Costsa.
Outcome | Emergency-Only Dialysis (n = 76) | Scheduled Dialysis (n = 105) | Difference-in-Differences (95% CI)c | P Value | ||||
---|---|---|---|---|---|---|---|---|
Baseline | Follow-up | Net Changeb | Baseline | Follow-up | Net Changeb | |||
Unadjusted Average Utilization Rates | ||||||||
ED visits per mo | 4.0 | 4.5 | +0.6 | 6.3 | 0.2 | −6.1 | −6.7 (−7.3 to −6.0) | <.001 |
Dialysis ED visits per mo | 3.5 | 4.3 | +0.8 | 5.6 | 0.0 | −5.5 | −6.3 (−7.0 to −5.7) | <.001 |
Non-dialysis ED visits per mo | 0.5 | 0.3 | −0.2 | 0.8 | 0.2 | −0.6 | −0.4 (−0.6 to −0.2) | <.001 |
Hospitalizations per 6 mo | 3.0 | 2.4 | −0.5 | 3.0 | 1.0 | −2.0 | −1.5 (−2.3 to −0.8) | <.001 |
Hospital d per 6 mo | 22.4 | 24.1 | +1.7 | 14.8 | 6.4 | −8.4 | −10.1 (−17.7 to −2.5) | .009 |
Adjusted Average Utilization Ratesd | ||||||||
ED visits per mo | 5.0 | 6.1 | +1.1 | 5.3 | 0.2 | −5.2 | −6.2 (−7.0 to −5.4) | <.001 |
Dialysis ED visits per mo | 4.4 | 5.6 | +1.2 | 4.8 | 0.0 | −4.7 | −6.0 (−6.7 to −5.2) | <.001 |
Non-dialysis ED visits per mo | 0.6 | 0.4 | −0.2 | 0.6 | 0.1 | −0.5 | −0.2 (−0.4 to −0.04) | .02 |
Hospitalizations per 6 mo | 2.9 | 2.3 | −0.5 | 3.1 | 1.0 | −2.1 | −1.6 (−2.3 to −0.8) | <.001 |
Hospital d per 6 mo | 19.2e | 20.0 | +0.8 | 16.7e | 7.6 | −9.2 | −9.9 (−17.1 to −2.7) | .007 |
Costs: Best-Case Scenariof | ||||||||
Unadjusted costs PPPM, $ | 8317 | 9581 | +1264 | 11 223 | 6288 | −4935 | −6199 (−8677 to −3721) | <.001 |
Adjusted costs PPPM, $d | 8691 | 10 146 | +1455 | 10 802 | 6090 | −4711 | −6166 (−8753 to −3579) | <.001 |
Costs: Worst-Case Scenariog | ||||||||
Unadjusted costs PPPM, $ | 8317 | 9581 | +1264 | 11 223 | 6697 | −4525 | −5790 (−8246 to −3333) | <.001 |
Adjusted costs PPPM, $d | 8686 | 10 138 | +1452 | 10 806 | 6490 | −4316 | −5768 (−8332 to −3204) | <.001 |
Abbreviations: ED, emergency department; PPPM, per person per month.
All utilization and costs were estimated per individual. We estimated costs per person per month by applying average national Medicare reimbursement rates for the following billed services to monthly event rates estimated for each individual: (1) emergency care and observation visits, (2) hospitalizations, (3) outpatient hemodialysis, (4) vascular access placement and/or complications. For further details, refer to the eMethods in the Supplement.
Values may not equal the exact difference in baseline and follow-up values due to rounding.
Difference-in-differences were estimated as the difference in net change in scheduled dialysis group minus net change in emergency-only group.
Adjusted for propensity score (age, sex, dialysis vintage, baseline ED visits, baseline hospital days, baseline serum albumin, baseline vascular access type).
In a sensitivity analysis, we omitted extreme outliers defined as individuals in the highest 99th percentile (n = 2). At baseline, the emergency-only group had an adjusted rate of 16.9 vs 15.9 hospital days per 6 mo in the scheduled group. At follow-up, the emergency-only group had an adjusted rate of 18.9 vs 7.1 hospital days per 6 mo in the scheduled group. The adjusted difference-in-differences estimate was −10.7 hospital days per 6 mo (95% CI −17.9 to −3.5, P = .003).
To estimate average health care costs PPPM in a best-case scenario with low vascular access complication rates, we applied vascular access complication rates observed in the late dialysis initiation arm of a previously published randomized controlled trial of early vs late dialysis initiation.28 For further details, refer to the eMethods in the Supplement.
To estimate average health care costs PPPM in a worst-case scenario with high vascular access complication rates, we applied vascular access complication rates observed during the first year after initial arteriovenous fistula placement in an observational study of older Medicare beneficiaries.29 For further details, refer to the eMethods in the Supplement.